Raquel Abalo

Raquel Abalo is a researcher affiliated with Victoria University, focusing on chemotherapy-induced gastrointestinal dysfunction and neurotoxicity. Her work bridges neuropharmacology, gastroenterology, and oncology, with a recurring emphasis on drug-induced enteric neuronal damage and pain mechanisms.

Recent articles highlight her exploration of cannabinoids (WIN 55,212-2) in visceral pain modulation, neuroprotection strategies (BGP-15 co-treatment), and molecular pathways in chemotherapy-induced motility disorders. Collaborations span neuroscience and clinical pharmacology, targeting conditions like colitis and platinum-based chemotoxicity.

Her studies systematically analyze

• Enteric nervous system integrity
• Neuroinflammation in colitis
• Anticancer drug side effects
• Redox signaling in neuronal damage
• Cholinergic neuron responses
• Novel therapeutic interventions

across multiple preclinical models.